Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mycobacterium Tuberculosis Complex Cell-free DNA (Mtb-cfDNA) for the Pharmacometric Assessment of Anti-tuberculosis Treatment: a Proof-of-concept Study

NCT06845618 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT06845618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06845618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mycobacterium Tuberculosis Complex Cell-free DNA (Mtb-cfDNA) for the Pharmacometric Assessment of Anti-tuberculosis Treatment: a Proof-of-concept Study
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Recruiting
Start date
July 21, 2025
Completion date
September 30, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mycobacterium tuberculosis, tuberculosis, extra-pulmonary, tuberculosis, pulmonary